Immune cell redirectors, also known as bispecific antibodies, are a class of immunotherapy designed to harness the body's immune system to target and destroy cancer cells. They work by simultaneously binding to a T-cell and a cancer cell, effectively bringing them together to facilitate the immune attack on the cancer.
